Bioprosthetic Tissue Stabilization via Antigenic Carbohydrate Modification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Bioprosthetic implants made from animal tissues face challenges such as hyperacute rejection reactions due to antigenic carbohydrate epitopes like α-GAL, leading to increased immunogenicity and calcification, which compromises their durability and stability over time.
Innovation Solution
Chemical modification of antigenic carbohydrates in bioprosthetic tissues using an oxidizing agent like periodate to form aldehydes, followed by treatment with a capping agent to form imines and a reducing agent to convert these into stable secondary amines, reducing antigenicity and calcification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If chemical fixation with glutaraldehyde is used to stabilize bioprosthetic tissue, then antigenicity is reduced, but calcification susceptibility increases and long-term stability deteriorates
Solution Approach 1:
The patent changes the chemical parameters of fixation by using alternative crosslinking agents (carbodiimides, epoxides, isocyanates, silanes) with different chemical properties than glutaraldehyde. These agents form more stable crosslinks that resist hydrolysis and maintain tissue stability long-term while reducing calcification susceptibility. The modification of crosslink chemistry directly addresses both the antigenicity reduction and long-term stability improvement.
Solution Approach 2:
The patent employs composite treatment approaches combining multiple crosslinking agents or sequential treatments (e.g., carbodiimide followed by epoxide, or combination with glycerol/phospholipids). These composite material strategies create synergistic effects that simultaneously reduce antigenicity through crosslinking while preventing calcification through hydrophobic modifications or calcium-binding agents, thereby improving overall tissue reliability.
2Stability of the object's composition
If glutaraldehyde fixation is applied to bioprosthetic tissue, then tissue stability is improved, but susceptibility to calcification increases
Solution Approach 1:
The patent converts the harmful effect of free aldehyde groups (which cause calcification) into a beneficial crosslinking mechanism. By using carbodiimides and epoxides that form stable amide and ether crosslinks respectively, the tissue achieves stability without generating the reactive aldehyde groups that attract calcium. The crosslinking function is preserved while the calcification-inducing property is eliminated.
Solution Approach 2:
The patent modifies the chemical composition parameters by introducing hydrophobic groups (through epoxide crosslinking or silane treatment) and calcium-binding agents (phospholipids, chelators) that alter the tissue's interaction with calcium ions. These parameter changes reduce the electrostatic attraction between tissue and calcium, thereby preventing calcification while maintaining structural stability.
3Strength
If cross-linking agents are used to stabilize bioprosthetic tissue, then structural integrity is improved, but residual reactive groups increase calcification risk
Solution Approach 1:
The patent uses carbodiimides (e.g., EDC, GDH) as zero-length crosslinking agents that form stable amide bonds without leaving residual reactive groups. These agents are completely consumed in the crosslinking reaction, leaving no persistent harmful residues. The crosslinking function is achieved through stoichiometric reaction, ensuring complete consumption of the crosslinking agent and elimination of residual reactivity.
Solution Approach 2:
The patent substitutes the aldehyde-based crosslinking mechanism (mechanism of glutaraldehyde forming Schiff bases) with alternative chemical mechanisms: carbodiimide-mediated amide bond formation, epoxide ring-opening crosslinking, isocyanate urea formation, or silane condensation. These substituted mechanisms achieve equivalent or superior structural integrity without generating residual reactive aldehydes that cause calcification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly reduces antigenicity and calcification, enhancing the stability, durability, and performance of bioprosthetic implants by eliminating reactive aldehydes and modifying latent antigens, thereby improving their long-term performance and reducing the risk of tissue failure.
Implementation Method 1
treating the bioprosthetic tissue with an oxidizing agent which oxidizes vicinal diol moieties of antigenic carbohydrates to form aldehydes
Implementation Method 2
treating the bioprosthetic tissue with a capping agent, the capping agent comprising a primary amine or alcohol which combines with the aldehydes to form imines
Implementation Method 3
treating the bioprosthetic tissue with a reducing agent, the reducing agent converting the imines to secondary amines
Data Source
AI summary
Methods are provided herein for modifying antigenic carbohydrate epitopes within a xenographic bioprosthetic tissue by oxidation of vicinal diols to form aldehydes or acids and subsequence reductive amination of aldehydes to form stable secondary amines, or amidation or esterification of acids to form stable amides or esters. Advantageously, methods provided herein mitigate the antigenicity of the bioprosthetic tissue while leaving the overall tissue structure substantially undisturbed, and thereby enhance the durability, safety and performance of the bioprosthetic implant.